Your browser doesn't support javascript.
loading
Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.
Khattab, Mohamed H; Newman, Neil B; Wharton, David M; Sherry, Alexander D; Luo, Guozhen; Manzoor, Nauman F; Rivas, Alejandro; Davis, L Taylor; Chambless, Lola B; Attia, Albert; Cmelak, Anthony J.
Afiliación
  • Khattab MH; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Newman NB; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Wharton DM; Vanderbilt University School of Medicine, Nashville, Tennessee, United States.
  • Sherry AD; Vanderbilt University School of Medicine, Nashville, Tennessee, United States.
  • Luo G; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Manzoor NF; Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Rivas A; Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Davis LT; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Chambless LB; Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Attia A; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
  • Cmelak AJ; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
J Neurol Surg B Skull Base ; 81(3): 308-316, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32500007
ABSTRACT
Management of vestibular schwannoma (VS) includes stereotactic radiosurgery (SRS) in single or fractionated treatments. There is a paucity of literature on the three-dimensional (3D) volumetric kinetics and radiological changes following SRS and no consensus on appropriate post-SRS surveillance imaging timeline. This is a retrospective cohort study with institutional review board approval. A total of 55 patients met study criteria. We collected volumetric kinetic data in VS treated with SRS over time using a target volume contouring software. We also tracked radiographic phenomena such as pseudoprogression and necrosis. A secondary objective was to describe our overall treatment success rate and any failures. For all treatments groups, pseudoprogression most typically occurred within 12 months post-SRS, after which tumor volumes on average normalized and then decreased from pretreatment size at the last follow-up. Only two patients required salvage therapy post-SRS and were considered SRS treatment failures. Both patients were in the five-fraction cohort but with a lower biologically equivalent dose. Our study is first to collect 3D volumetric kinetics of VS following single and fractionated SRS in contrast to extrapolations from single and two-dimensional measurements. Our longitudinal data also show initial increases in volume in the first 12 months post-SRS followed by later declines, setting up interesting questions regarding the utility of early posttreatment surveillance imaging in the asymptomatic patient. Finally, we show low rates of treatment failure (3.6%) and show in our cohort that SRS dose de-escalation posed a risk of treatment failure.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Año: 2020 Tipo del documento: Article